Inflammatory Bowel Disease Therapeutics - A Global Strategic Business Report
Over 2 million people across Europe, the US and Japan suffer from one of the two inflammatory bowel diseases, as stated by the new market research report on inflammatory bowel disease therapeutics market. The number is expected to grow considerably in near future, acting as a major driving force for the IBD therapeutics market. Prevalence of IBD is higher in developed countries of Europe, Americas and Japan, as compared to rest of world. The disease still lacks awareness among the...
View full press release